[HTML][HTML] A new venue of TNF targeting
S Steeland, C Libert, RE Vandenbroucke - International journal of …, 2018 - mdpi.com
The first Food and Drug Administration-(FDA)-approved drugs were small, chemically-
manufactured and highly active molecules with possible off-target effects, followed by …
manufactured and highly active molecules with possible off-target effects, followed by …
A New Venue of TNF Targeting
S Steeland, C Libert, RE Vandenbroucke - 2018 - preprints.org
The first FDA-approved drugs were small, chemically-manufactured and highly active
molecules with possible off-target effects. After this first successful wave of small drugs …
molecules with possible off-target effects. After this first successful wave of small drugs …
A New Venue of TNF Targeting
S Steeland, C Libert… - International journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
The first Food and Drug Administration-(FDA)-approved drugs were small, chemically-
manufactured and highly active molecules with possible off-target effects, followed by …
manufactured and highly active molecules with possible off-target effects, followed by …
[PDF][PDF] A new venue of TNF targeting 2
S Steeland, C Libert, RE Vandenbroucke - 2018 - scholar.archive.org
The first FDA-approved drugs were small, chemically-manufactured and highly active 13
molecules with possible off-target effects. After this first successful wave of small drugs …
molecules with possible off-target effects. After this first successful wave of small drugs …
[HTML][HTML] A New Venue of TNF Targeting
S Steeland, C Libert… - International Journal of …, 2018 - ncbi.nlm.nih.gov
Abstract The first Food and Drug Administration-(FDA)-approved drugs were small,
chemically-manufactured and highly active molecules with possible off-target effects …
chemically-manufactured and highly active molecules with possible off-target effects …
A new venue of TNF targeting
S Steeland, C Libert… - INTERNATIONAL …, 2018 - biblio.ugent.be
The first Food and Drug Administration-(FDA)-approved drugs were small, chemically-
manufactured and highly active molecules with possible off-target effects, followed by …
manufactured and highly active molecules with possible off-target effects, followed by …
[PDF][PDF] A New Venue of TNF Targeting
S Steeland, C Libert, RE Vandenbroucke - Int. J. Mol. Sci, 2018 - pdfs.semanticscholar.org
The first Food and Drug Administration-(FDA)-approved drugs were small,
chemicallymanufactured and highly active molecules with possible off-target effects …
chemicallymanufactured and highly active molecules with possible off-target effects …
A New Venue of TNF Targeting.
S Steeland, C Libert… - International Journal of …, 2018 - search.ebscohost.com
Abstract The first Food and Drug Administration-(FDA)-approved drugs were small,
chemically-manufactured and highly active molecules with possible off-target effects …
chemically-manufactured and highly active molecules with possible off-target effects …
A New Venue of TNF Targeting
S Steeland, C Libert, RE Vandenbroucke - (No Title), 2018 - cir.nii.ac.jp
抄録< jats: p> The first FDA-approved drugs were small, chemically-manufactured and
highly active molecules with possible off-target effects. After this first successful wave of …
highly active molecules with possible off-target effects. After this first successful wave of …
A New Venue of TNF Targeting.
S Steeland, C Libert… - International Journal of …, 2018 - europepmc.org
Abstract The first Food and Drug Administration-(FDA)-approved drugs were small,
chemically-manufactured and highly active molecules with possible off-target effects …
chemically-manufactured and highly active molecules with possible off-target effects …